recent
advanc
nucleic
acid
diagnost
technolog
revolution
microbiolog
facilit
rapid
sensit
pathogen
surveil
differenti
diagnosi
infecti
diseas
expans
dissemin
genom
sequenc
technolog
scientist
discov
new
microb
acceler
pace
articl
review
recent
progress
fi
eld
pathogen
surveil
discoveri
specifi
c
focu
applic
fi
eld
laboratori
anim
research
discuss
challeng
prove
causal
relationship
presenc
candid
organ
diseas
also
discuss
strength
limit
variou
assay
platform
describ
stage
strategi
viral
diagnost
illustr
complex
pursu
pathogen
discoveri
research
includ
exampl
work
intend
provid
insight
process
led
select
particular
strategi
ncreasingli
global
travel
trade
climat
chang
effect
distribut
phlebotom
arthropod
vector
shift
demograph
land
use
usher
era
infecti
diseas
outbreak
pandem
mors
advent
potent
threat
health
econom
welfarehuman
immunodefici
viru
hiv
sever
acut
respiratori
syndrom
sar
swine
infl
uenza
avian
infl
uenza
creat
unpreced
support
basic
translat
research
host
vector
microb
abbrevi
use
articl
cpcr
consensu
pcr
pcr
polymeras
chain
reaction
rtpcr
realtim
pcr
sar
sever
acut
respiratori
syndrom
ogi
well
diagnost
surveil
vaccin
therapeut
new
molecular
platform
masstag
polymeras
chain
reaction
pcr
bries
et
al
lamson
et
al
palacio
et
al
renwick
et
al
microbi
microarray
chiu
et
al
palacio
et
al
wang
et
al
unbias
highthroughput
pyrosequenc
coxfost
et
al
enabl
effi
cient
differenti
diagnosi
pathogen
discoveri
surveil
clinic
infecti
diseas
addit
enhanc
surveil
wildlif
domest
anim
known
vector
eg
rodent
mosquito
especi
hot
spot
infecti
diseas
emerg
better
prepar
public
health
medic
research
commun
predict
avert
next
pandem
deem
et
al
jone
et
al
wolf
et
al
health
surveil
laboratori
anim
essenti
adventiti
infect
continu
challeng
anim
welfar
research
rodent
parvovirus
helicobact
spp
murin
noroviru
previous
unknown
infecti
agent
recent
emerg
laboratori
rodent
agent
discov
serendipit
activ
investig
atyp
serolog
result
cell
cultur
contamin
unexpect
histopatholog
previous
unrecogn
clinic
diseas
syndrom
although
daunt
expens
proposit
facil
establish
clean
coloni
strict
quarantin
breed
polici
need
preserv
critic
transgen
line
embryo
transfer
smith
differ
scenario
pertain
work
nonhuman
primat
given
longer
gener
time
domest
product
meet
current
project
research
need
rhesu
macaca
mulatta
cynomolgu
fasciculari
macaqu
import
anim
play
increasingli
critic
role
forese
futur
two
type
macaqu
avail
import
southeast
asia
mauritiu
lack
nation
intern
standard
microbi
qualiti
control
research
anim
anim
repres
undefi
ned
uncharacter
popul
regard
infecti
parasit
agent
signifi
canc
problem
underscor
recent
outbreak
tuberculosi
measl
simian
malaria
detect
antibioticresist
shigella
fl
exneri
recent
import
rhesu
chines
origin
wellpublic
outbreak
hemorrhag
diseas
subsequ
recognit
previous
unknown
ebolareston
viru
cynomolgu
macaqu
import
philippin
jahrl
et
al
possibl
elimin
pathogen
nonhuman
primat
coloni
import
defi
ne
spectrum
microbi
agent
present
popul
anim
understand
agent
infl
uenc
pathobiolog
experiment
work
mansfi
eld
kemnitz
infecti
parasit
diseas
may
advers
affect
research
program
sever
way
lerch
osborn
mani
agent
welldocu
pathogen
caus
overt
morbid
mortal
unrecogn
adventiti
agent
common
nonhuman
primat
potenti
confound
experiment
studi
nonpathogen
commens
agent
normal
host
speci
may
repres
zoonot
diseas
risk
human
contact
eg
macacin
herpesviru
becom
pathogen
normal
host
secondari
experiment
manipul
immunosuppress
presenc
undetect
microbi
agentspathogen
nonpathogen
alikerepres
potenti
threat
health
statu
breed
coloni
human
contact
research
integr
thu
one
biggest
challeng
research
use
import
nonhuman
primat
need
improv
diagnost
tool
screen
infecti
parasit
agent
robert
andrew
simmon
indic
presenc
microbi
organ
fi
rst
step
elucid
relationship
diseas
acut
infecti
diseas
agent
often
isol
morpholog
chang
correl
distribut
agent
serolog
provid
evid
adapt
immun
respons
howev
agent
cultur
clinic
sign
symptom
infect
specifi
c
particular
organ
furthermor
factor
host
genet
suscept
age
nutrit
previou
exposur
similar
agent
may
modul
express
diseas
implic
agent
may
diffi
cult
classic
hallmark
infect
absent
mechan
pathogenesi
indirect
subtl
case
investig
must
resort
statist
assess
strength
epidemiolog
associ
base
presenc
agent
footprint
nucleic
acid
antigen
prefer
immun
respons
biolog
plausibl
indic
analog
diseas
relat
organ
linkag
persuas
evid
may
suffi
cient
merit
intervent
trial
exampl
includ
hepat
b
papillomavirus
human
infect
vaccin
prevent
infect
candid
organ
reduc
incid
hepat
cervic
neoplasia
respect
review
typic
focu
latest
molecular
technolog
clinic
acumen
patholog
serolog
classic
cultur
techniqu
still
play
pivot
role
pathogen
discoveri
clinician
epidemiologist
appreci
appear
anomali
collect
materi
investig
persuad
laboratori
colleagu
invest
search
known
novel
pathogen
immunohistochemistri
instrument
direct
molecular
work
exploit
crossreact
properti
antisera
reveal
presenc
agent
relat
origin
immunogen
potenc
approach
underscor
fact
discoveri
sin
nombr
viru
chizhikov
et
al
nipah
viru
paton
et
al
west
nile
viru
wnv
bries
et
al
lanciotti
et
al
shieh
et
al
steel
et
al
lujo
viru
facilit
demonstr
viral
protein
tissu
turn
allow
focus
consensu
pcr
cpcr
analys
classic
method
tissu
cultur
serolog
also
import
tissu
cultur
pivot
sar
outbreak
peiri
et
al
wherein
growth
viru
enabl
rapid
character
use
cpcr
random
prime
cdna
librari
microarray
electron
microscopi
sinc
advent
pcr
method
clone
microbi
nucleic
acid
directli
clinic
specimen
becom
commonplac
pathogen
surveil
discoveri
past
decad
subtract
clone
express
clone
cpcr
highthroughput
pyrosequenc
result
identifi
cation
follow
novel
agent
addit
lujo
nipah
sin
nombr
virus
associ
acut
chronic
diseas
borna
diseas
viru
hepat
c
viru
human
herpesviru
hhv
bartonella
hensela
tropheryma
whipplii
sar
coronaviru
israel
acut
paralysi
viru
challon
et
al
chang
et
al
choo
et
al
coxfost
et
al
lipkin
et
al
nichol
et
al
paton
et
al
peiri
et
al
relman
et
al
relman
et
al
vandewoud
et
al
sensit
molecular
assay
primer
probe
perfect
complementar
singl
genet
target
exampl
includ
fl
uoresc
reporterbas
taqman
molecular
beacon
singleplex
pcr
assay
may
detect
threshold
low
rna
molecul
ideal
applic
focus
detect
presenc
specifi
c
agent
quantit
viral
burden
heid
et
al
tyagi
kramer
yet
assay
fail
virus
character
high
mutat
rate
genet
variabl
degener
primer
probe
design
accommod
sequenc
diverg
although
typic
entail
compromis
sensit
perhap
signifi
cant
confound
sign
symptom
diseas
rare
agentspecifi
c
particularli
earli
clinic
cours
thu
unless
investig
suffi
cient
sampl
resourc
time
invest
mani
singleplex
assay
differ
agent
risk
wrong
candid
select
among
mani
potenti
pathogen
overlap
clinic
present
common
singleplex
assay
use
clinic
microbiolog
microbi
surveil
pcr
assay
enabl
detect
fl
uoresc
signal
dna
strand
replic
result
either
cleavag
releas
label
oligonucleotid
probe
bound
sequenc
forward
revers
primer
equip
need
modest
thermal
cycler
fl
uoresc
reader
laptop
comput
reliabl
fl
uoresc
reporterdy
singleplex
assay
achiev
fi
eld
condit
batteri
power
necessari
loopmedi
isotherm
amplifi
cation
lamp
altern
pcr
requir
programm
thermal
cycler
hagiwara
et
al
notomi
et
al
shirato
et
al
although
sensit
report
similar
pcr
lamp
quantit
product
typic
detect
ethidium
bromidestain
agaros
gel
chang
turbid
amplifi
cation
solut
may
suffi
cient
inde
accord
least
one
studi
accumul
product
detect
eye
jayawardena
et
al
nest
pcr
two
amplifi
cation
reaction
pursu
sequenti
either
one
heminest
two
fulli
nest
primer
locat
respect
origin
primer
set
may
sensit
fl
uoresc
reporterdy
singleplex
assay
howev
potenti
contamin
higher
origin
reaction
must
open
add
reagent
second
nest
reaction
casa
et
al
templeton
et
al
nest
pcr
challeng
even
laboratori
scrupul
experiment
hygien
represent
differ
analysi
rda
import
tool
pathogen
identifi
cation
discoveri
howev
subtract
clone
method
binari
comparison
nucleic
acid
popul
hubank
et
al
lisitsyn
et
al
thu
although
ideal
analysi
clone
cell
tissu
sampl
differ
singl
variabl
interest
rda
less
well
suit
investig
infect
sever
differ
pathogen
result
similar
clinic
manifest
invari
associ
diseas
addit
caveat
method
requir
presenc
limit
number
restrict
site
rda
like
succeed
agent
larg
genomesinde
two
virus
detect
rda
herpesvirus
challon
et
al
chang
et
al
consensu
pcr
also
remark
product
tool
biolog
strand
et
al
addit
identifi
pathogen
method
facilit
identifi
cation
wide
varieti
host
molecul
includ
cytokin
ion
channel
receptor
also
present
limit
exampl
use
pathogen
discoveri
virolog
diffi
cult
identifi
conserv
viral
sequenc
suffici
length
allow
cross
hybrid
amplifi
cation
discrimin
tradit
cpcr
format
although
may
problemat
one
target
singl
viru
genu
number
assay
requir
becom
infeas
preliminari
data
insuffi
cient
permit
direct
effi
cient
analysi
address
problem
adapt
cpcr
differenti
display
pcrbase
method
simultan
display
genet
composit
multipl
sampl
popul
acrylamid
gel
liang
parde
hybrid
method
known
domainspecifi
c
differenti
display
employ
short
degener
primer
set
design
hybrid
viral
gene
repres
larger
taxonom
categori
resolv
cpcr
modifi
cation
allow
us
identifi
wnv
caus
agent
new
york
citi
enceph
outbreak
resolv
issu
low
throughput
cpcr
due
limit
multiplex
multiplex
assay
allow
investig
mani
hypothes
simultan
time
diffi
cult
establish
singleplex
assay
individu
target
primer
set
need
share
optim
reaction
condit
eg
anneal
temperatur
magnesium
concentr
moreov
complex
primer
mixtur
prone
primerprim
interact
reduc
assay
sensit
andor
specifi
citi
specifi
c
softwar
tool
avail
autom
consensu
primer
design
multipl
sequenc
align
allow
user
specifi
primer
length
melt
temperatur
degre
degeneraci
compat
multiplex
pcr
approach
gelbas
multiplex
assay
wherein
product
distinguish
size
detect
mani
distinct
target
albeit
low
sensit
casa
et
al
templeton
et
al
design
yet
cumbersom
other
set
sinc
add
addit
constraint
pcr
product
need
resolv
adequ
electrophoresi
fluoresc
reporterbas
multiplex
assay
sensit
limit
numberfourof
fl
uoresc
emiss
peak
unequivoc
separ
sloppi
molecular
beacon
circumv
limit
part
bind
relat
target
differ
melt
temperatur
saunder
jeffri
howev
detect
target
differ
nucleotid
improv
approach
multiplex
capac
gelbas
assay
two
multiplex
platform
join
pcr
mass
spectroscopi
ms
sensit
detect
sever
target
one
triangul
identifi
cation
genet
evalu
risk
tiger
use
matrixassist
laser
desorptionion
maldi
ms
directli
measur
molecular
weight
pcr
product
obtain
experiment
sampl
compar
databas
known
predict
product
weight
hofstadl
et
al
sampath
et
al
van
ert
et
al
tiger
use
cpcr
detect
virus
given
speci
genu
compar
signatur
databas
known
agent
potenti
directli
indic
candid
novel
variant
known
organ
via
diverg
product
mass
requir
sequenc
character
novel
sequenc
agent
maldim
tiger
confi
ned
special
laboratori
possibl
multiplex
limit
detect
member
famili
genu
speci
system
masstag
pcr
use
atmospher
pressur
chemic
ioniz
apci
ms
read
molecular
weight
report
tag
attach
pcr
primer
bries
et
al
palacio
et
al
apcim
masstag
pcr
perform
smaller
less
expens
portabl
instrument
syndromespecifi
c
masstag
pcr
panel
enabl
rapid
differenti
virus
bacteria
fungi
parasit
associ
acut
respiratori
diseas
diarrhea
pustular
diseas
encephalitismening
tickborn
associ
infecti
agent
hemorrhag
fever
bries
et
al
lamson
et
al
palacio
et
al
tokarz
et
al
multiplex
pcr
system
use
fl
ow
cytometri
detect
amplifi
cation
product
bound
match
oligonucleotid
fl
uoresc
bead
brunstein
thoma
han
et
al
li
et
al
sensit
similar
across
platform
whether
becom
domin
commerci
arena
remain
seen
viral
microarray
broadli
divid
address
agent
design
detect
thousand
agent
includ
unknown
array
second
categori
eg
respiratori
viru
resequenc
array
may
use
multiplex
cpcr
amplifi
specifi
c
genet
target
chiu
et
al
chiu
et
al
miro
et
al
wong
et
al
sampl
prepar
complex
sensit
clinic
materi
typic
rna
copi
although
array
typic
use
probe
less
nucleotid
nt
may
allow
speciat
agent
truli
exploit
util
microarray
unbias
microb
detect
oligonucleotid
microarray
compris
hundr
thousand
featur
probe
nt
uncommon
thu
unlik
pcr
resequenc
array
short
primer
sequenc
demand
precis
complementar
probe
target
array
less
like
confound
minor
sequenc
mismatch
addit
one
incorpor
microbi
host
gene
target
highdens
array
afford
opportun
detect
microb
assess
host
respons
signatur
consist
variou
class
infecti
agent
two
familiar
larger
scope
platform
virochip
greenechip
wang
et
al
differ
method
use
probe
design
array
manufactur
hybrid
condit
bioinformat
analysi
hybrid
result
common
sampl
nucleic
acid
randomli
amplifi
ed
label
unbias
amplifi
cation
critic
exploit
full
rang
probe
repres
ten
thousand
viral
target
howev
host
microb
sequenc
compet
similar
effi
cienci
pcr
reagent
sensit
microbi
detect
commonli
low
copi
surpris
therefor
success
applic
technolog
assay
clinic
sampl
low
host
nucleic
acid
content
eg
serum
cerebrospin
fl
uid
urin
improv
sensit
copi
achiev
challeng
tissu
sampl
deplet
host
cell
dna
ribosom
rna
rrna
amplifi
cation
label
use
report
label
dendrim
bind
hybrid
sequenc
enhanc
overal
signal
intens
array
platform
hybrid
detect
chang
electr
conduct
yet
extend
highdens
microarray
potenti
enabl
improv
sensit
viral
array
facilit
clone
sequenc
analysi
well
pathogen
identifi
cation
hybrid
product
typic
rang
nt
nt
array
display
probe
repres
sever
differ
genom
region
viru
one
rapidli
recov
sequenc
hybrid
product
also
sequenc
product
use
pcr
method
simpl
hybrid
product
elut
hot
water
reamplifi
ed
use
specifi
c
sequenc
portion
primer
origin
use
random
amplifi
cation
highthroughout
sequenc
afford
uniqu
opportun
pathogen
discoveri
unlik
cpcr
array
method
investig
limit
known
sequenc
inform
must
make
choic
rang
pathogen
consid
given
experi
highthroughput
sequenc
unbias
make
possibl
consid
entir
tree
life
bacteria
virus
fungi
parasit
experi
primarili
pyrosequenc
system
life
scienc
principl
sampl
prepar
data
analysi
broadli
applic
across
platform
marguli
et
al
viral
microarray
analys
elimin
host
nucleic
acid
critic
boost
pathogen
signal
toward
threshold
detect
although
approach
reduc
potenti
detect
dna
genom
pathogen
reason
activ
infect
associ
transcript
amplifi
cation
sequenc
read
typic
rang
size
base
pair
raw
sequenc
read
trim
remov
sequenc
deriv
amplifi
cation
primer
fi
ltere
elimin
highli
repetit
sequenc
trim
elimin
repeat
sequenc
cluster
nonredund
sequenc
set
uniqu
sequenc
read
assembl
contigu
sequenc
compar
nonredund
sequenc
databas
use
program
examin
homolog
nucleotid
amino
acid
level
use
six
potenti
read
frame
palacio
et
al
view
platform
describ
complementari
tool
due
eas
use
sensit
capac
quantit
low
cost
singleplex
pcr
ideal
instanc
question
relat
presenc
singl
agent
viral
burden
exampl
includ
outbreak
acut
infecti
diseas
decis
concern
patient
contain
alloc
specifi
c
intervent
short
suppli
potenti
toxic
adjust
antivir
regimen
hiv
infect
multiplex
assay
indic
singleplex
pcr
fail
identifi
agent
clinic
present
context
pathognomon
infect
singl
agent
timeand
costeffect
altern
secondstag
analys
multiplex
pcr
platform
fail
list
candid
agent
exce
microarray
indic
multiplex
pcr
microarray
platform
requir
agent
relat
one
alreadi
known
instanc
agent
novel
suffi
cientli
distant
sequenc
relat
agent
confound
hybrid
may
necessari
pursu
subtract
clone
unbias
highthroughput
sequenc
irrespect
method
result
identifi
cation
pathogen
candid
subsequ
step
includ
quantit
pathogen
burden
affect
host
control
detail
character
pathogen
featur
may
contribut
virul
provid
clue
proven
serolog
index
acut
infect
tool
examin
preval
infect
time
geographi
although
unbias
highthroughput
sequenc
becom
increasingli
popular
tool
pathogen
discoveri
cost
decreas
may
fail
agent
present
low
level
sequenc
differ
commonli
use
algorithm
detect
microbi
subtract
clone
may
succeed
unbias
highthroughput
sequenc
fail
boost
nonhost
signal
inde
use
enhanc
effi
cienci
unbias
highthroughput
sequenc
platform
borna
diseas
viru
fi
rst
agent
discov
unbias
molecular
method
lipkin
et
al
would
found
consensu
pcr
microarray
highthroughput
sequenc
genom
sequenc
dissimilar
agent
new
analyt
model
base
neurolinguist
cryptographi
may
facilit
recognit
microbi
sequenc
even
lack
similar
known
microb
primari
sequenc
level
stori
molecular
character
borna
diseas
viru
bdv
illustr
far
fi
eld
pathogen
discoveri
evolv
past
year
bdv
known
unclassifi
ed
infecti
agent
name
town
saxoni
eastern
germani
larg
outbreak
equin
enceph
late
rott
koprowski
report
serum
patient
bipolar
disord
react
bdvinfect
cell
rott
et
al
concept
infect
might
implic
neuropsychiatr
diseas
intrigu
us
challeng
fact
establish
method
viru
isol
fail
other
began
pursu
character
use
molecular
tool
isol
bdv
nucleic
acid
subtract
hybrid
fi
rst
success
applic
techniqu
pathogen
discoveri
lipkin
et
al
fact
perform
reli
home
brew
kit
cdna
clone
preced
advent
pcr
readi
access
sequenc
technolog
underscor
challeng
microb
hunter
face
even
year
ago
sequenc
mainstream
technolog
time
fi
rst
cdna
obtain
furthermor
even
avail
research
would
appreci
similar
bdv
virus
associ
clone
mate
rial
diseas
achiev
demonstr
candid
cdna
compet
rna
templat
brain
infect
rat
transcript
translat
protein
biomark
present
brain
hybrid
arrest
experi
distribut
candid
nucleic
acid
correl
patholog
brain
experiment
infect
rat
natur
infect
hors
situ
hybrid
signal
obtain
southern
hybrid
experi
wherein
normal
brain
probe
candid
clone
next
year
genom
clone
viru
visual
classifi
ed
prototyp
new
famili
nonseg
negativestrand
nn
rna
viru
unusu
properti
nuclear
replicationtranscript
posttranscript
modifi
cation
select
mrna
speci
splice
lowlevel
product
broad
host
rang
neurotrop
capac
persist
bries
et
al
bries
et
al
cubitt
et
al
de
la
torr
schneemann
et
al
schneider
et
al
although
wide
believ
introduct
specifi
c
reagent
recombin
protein
nucleic
acid
probe
would
allow
rapid
assess
role
bdv
human
diseas
still
conclus
evid
viru
infect
human
could
consid
classic
exampl
pitfal
pcr
diagnost
particularli
use
nest
method
bdv
erron
implic
wide
varieti
disordersunipolar
depress
bipolar
disord
schizophrenia
chronic
fatigu
syndrom
aid
encephalopathi
multipl
sclerosi
motor
neuron
diseas
brain
tumor
glioblastoma
multiform
lipkin
et
al
schwemml
et
al
nonetheless
bdv
discoveri
fundament
emerg
intrigu
new
model
viral
pathogenesi
moreov
research
provid
invalu
guidanc
regard
method
investig
role
infect
chronic
diseas
sensit
molecular
tool
introduct
pcr
chang
landscap
pathogen
discoveri
stori
discoveri
west
nile
viru
north
america
exampl
power
technolog
also
instrument
demonstr
import
expand
infecti
diseas
surveil
beyond
human
domest
anim
wildlif
late
august
health
offi
cial
report
outbreak
enceph
accompani
profound
weak
queen
new
york
recognit
syndrom
due
appar
increas
frequenc
enceph
per
se
automat
report
event
result
detect
outbreak
clinic
acumen
deborah
asni
infecti
diseas
physician
flush
hospit
medic
center
marcel
layton
assist
commission
communic
diseas
program
new
york
citi
depart
health
associ
earli
septemb
serolog
presenc
antibodi
north
american
arbovirus
yield
result
consist
infect
st
loui
enceph
viru
slev
asni
et
al
although
mosquito
vector
compet
transmiss
slev
present
viru
previous
report
state
earli
victim
outbreak
histori
consist
mosquito
exposur
investig
outbreak
epicent
consist
nearbi
exist
site
activ
mosquito
breed
thu
septemb
state
citi
new
york
implement
mosquito
erad
program
concurr
wildlif
observ
independ
note
increas
mortal
avian
speci
includ
freerang
crow
exot
bird
hous
bronx
zoo
traci
mcnamara
veterinari
pathologist
wildlif
conserv
societi
perform
histolog
analysi
bird
found
meningoenceph
gross
hemorrhag
brain
splenomegali
myocard
steel
et
al
although
emerg
infecti
diseas
zoonos
instanc
coincid
human
nonhuman
outbreak
strike
mcnamara
unabl
persuad
colleagu
human
infecti
diseas
surveil
review
materi
forward
tissu
sampl
diseas
bird
us
depart
agricultur
usda
nation
veterinari
servic
laboratori
ame
iowa
viru
cultur
electron
micrograph
consist
presenc
either
togaviru
fl
aviviru
avian
viru
forward
usda
center
diseas
control
prevent
cdc
divis
vectorborn
infecti
diseas
fort
collin
molecular
analysi
septemb
cdc
enceph
project
compris
center
california
new
york
tennesse
held
annual
meet
albani
new
york
data
california
new
york
survey
period
indic
despit
cultur
serolog
molecular
analys
case
viral
enceph
remain
without
etiolog
agent
sherif
zaki
cdc
atlanta
demonstr
presenc
fl
aviviru
protein
brain
human
victim
new
york
citi
outbreak
effort
amplifi
slev
fl
avivir
sequenc
convent
realtim
rt
pcr
unsuccess
group
invit
discuss
method
identifi
cation
unknown
pathogen
consid
applic
project
sampl
use
sever
degener
primer
set
design
target
highli
conserv
domain
untransl
region
fl
avivirus
obtain
posit
result
four
fi
new
york
patient
hour
sequenc
analysi
confi
rmed
presenc
lineag
wnv
jia
et
al
concurr
colleagu
cdc
fort
collin
report
west
nilelik
sequenc
cell
line
infect
homogen
new
york
bird
fi
nding
confi
rmed
outbreak
new
york
citi
zoonosi
due
west
nile
viru
subsequ
establish
quantit
rtpcr
assay
sensit
highthroughput
detect
viru
clinic
materi
mosquito
pool
although
analysi
blood
sampl
infect
human
reveal
presenc
wnv
sequenc
late
bries
et
al
signifi
canc
humanhuman
transmiss
appreci
transmiss
organ
transplant
blood
transfus
led
implement
blood
screen
nucleic
acid
amplifi
cation
test
cdc
cdc
outbreak
underscor
signifi
canc
enhanc
commun
human
compar
medicin
commun
infl
uenza
season
new
york
state
depart
health
receiv
sampl
cdc
infl
uenza
surveil
system
sampl
analyz
use
antigen
detect
rtpcr
assay
design
identifi
infl
uenza
virus
well
convent
viru
cultur
detect
addit
respiratori
viral
pathogen
analys
identifi
ed
candid
agent
sampl
neg
sampl
collect
day
onset
symptom
low
microbi
load
time
collect
could
account
assay
failur
howev
mani
neg
sampl
cluster
octob
decemb
observ
compat
circul
unidentifi
ed
agent
interv
pursu
hypothesi
use
masstag
pcr
panel
target
infl
uenza
virus
b
human
respiratori
syncyti
virus
b
human
coronavirus
sar
human
parainfl
uenza
virus
human
metapneumoviru
human
enteroviru
hev
human
adenoviru
mycoplasma
pneumonia
legionella
pneumophila
chlamydia
pneumonia
streptococcu
pneumonia
haemophilu
infl
uenza
neisseria
meningitidi
masstag
pcr
identifi
ed
pathogen
previous
neg
specimen
lamson
et
al
degener
hev
primer
use
masstag
pcr
assay
amplifi
conserv
region
untransl
region
utr
picornavirus
also
found
human
rhinovirus
hrv
sampl
test
posit
primer
pair
test
specifi
c
diagnost
rtpcr
assay
hev
case
yield
neg
result
reason
product
repres
either
novel
hev
hrv
isol
clone
masstag
pcr
amplifi
cation
product
sequenc
analysi
identifi
ed
hev
hrv
detail
phylogenet
analys
gene
region
indic
eight
case
repres
novel
rhinoviru
clade
distinct
group
b
serotyp
followup
studi
europ
australia
asia
confi
rmed
intern
distribut
virus
reveal
novel
genet
clade
play
major
role
pediatr
asthma
pneumonia
kistler
et
al
lau
et
al
mcerlean
et
al
renwick
et
al
time
write
report
repres
novel
clade
grown
cultur
studi
confi
rm
import
novel
multiplex
molecular
method
surveil
outbreak
detect
epidemiolog
decemb
three
patient
melbourn
australia
receiv
solid
organ
transplant
day
singl
donor
palacio
et
al
donor
report
good
health
die
hemorrhag
stroke
approxim
day
return
australia
trip
southeastern
europ
three
organ
recipi
die
week
transplant
clinic
cours
mark
fever
encephalopathi
extens
preand
postmortem
workup
bacteri
viral
cultur
well
pcr
wide
rang
bacteri
viral
pathogen
unininform
masstag
pcr
greenechip
microarray
assay
rna
recipi
organ
plasma
cerebrospin
fl
uid
yield
evid
infect
rna
subject
unbias
highthroughput
pyrosequenc
yield
total
nucleotid
sequenc
use
bioinformat
algorithm
human
sequenc
subtract
nucleotid
deduc
amino
acid
sequenc
compar
genet
databas
identifi
relat
microbi
sequenc
wherea
ssegment
sequenc
recogniz
nucleotid
level
footprint
lsegment
detect
amino
acid
level
consist
previous
unknown
old
world
arenaviru
specifi
c
pcr
analys
confi
rmed
presenc
viru
recipi
tissu
homogen
organ
highest
viral
rna
titer
use
inocul
cell
cultur
line
infect
cell
use
develop
indirect
immunofl
uoresc
assay
serolog
obtain
electron
micrograph
agent
septemb
woman
recent
onset
sever
headach
fever
chest
pain
pharyng
admit
hospit
lusaka
zambia
rapidli
deterior
transfer
air
johannesburg
south
africa
special
care
fl
ight
physician
paramed
attend
pulmonari
toilet
manual
ventil
arriv
johannesburg
comatos
cerebr
edema
acut
respiratori
distress
syndrom
renal
failur
die
shortli
thereaft
autopsi
perform
bodi
return
zambia
cremat
physician
paramed
attend
air
evacu
nurs
care
johannesburg
custodian
respons
clean
hospit
room
develop
similar
clinic
syndrom
fatal
outcom
initi
workup
clinic
materi
fail
identifi
caus
agent
outbreak
world
health
organ
coordin
multicent
diagnost
effort
nation
institut
communic
diseas
south
africa
cdc
columbia
univers
immunohistochemistri
reveal
footprint
arenaviru
cpcr
confi
rmed
presenc
within
hour
sampl
receipt
unbias
highthroughput
pyrosequenc
yield
nearli
complet
genom
inform
novel
arenaviru
name
lujo
viru
lusaka
johannesberg
paweska
et
al
base
data
fi
fth
case
acut
ill
nurs
care
one
secondari
victim
identifi
ed
contact
trace
treat
antivir
drug
ribavirin
recov
time
cours
lujo
outbreak
rapid
agent
identifi
ed
character
illustr
power
sequenc
technolog
public
health
person
medicin
mani
tool
describ
avail
special
laboratori
industri
world
unlik
full
complement
technolog
broadli
avail
near
futur
essenti
establish
capac
differenti
diagnosi
infecti
diseas
develop
world
risk
burden
hemorrhag
fever
promin
toward
end
encourag
academician
public
health
practition
corpor
partner
begin
focu
smaller
footprint
solut
phase
microarray
platform
promis
perform
resourcepoor
environ
invest
surveil
bush
meat
wildlif
domest
anim
human
geograph
hot
spot
increas
risk
emerg
infecti
diseas
emerg
long
overdu
encourag
recent
increas
support
proactiv
effort
detect
technolog
continu
evolv
allow
faster
sensit
less
expens
method
pathogen
surveil
discoveri
multiplex
pcr
assay
alreadi
wide
implement
microarray
technolog
less
advanc
improv
develop
includ
microfl
uidic
sampl
process
direct
measur
conduct
chang
associ
hybrid
although
address
proteom
host
respons
profi
ling
investig
may
yet
discov
biomark
either
specifi
c
class
infecti
agent
provid
insight
guid
clinic
manag
activ
collabor
clinician
laboratorian
key
success
diagnost
advanc
technolog
fail
sampl
collect
without
attent
nucleic
acid
labil
data
uninterpret
without
accur
inform
clinic
cours
sampl
proven
chronic
diseas
complex
mechan
earli
exposur
andor
genet
suscept
may
contribut
pathogenesi
substant
advanc
link
microb
diseas
like
come
invest
prospect
serial
sampl
collect
appreci
mani
diseas
refl
ect
intersect
gene
speci
environ
tempor
context
